<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(2)</volume><submitter>Xiong Y</submitter><pubmed_abstract>Hepatic ischemia-reperfusion (I/R) injury frequently occurs during the perioperative phase of liver surgery. Inappropriate activation of STING signaling can trigger excessive inflammation response to aggravate hepatic I/R injury. Dimethyl fumarate (DMF) is an FDA-approved immunomodulatory drug used to treat multiple sclerosis and psoriasis due to its notable anti-inflammation properties. However, the mechanism and targets of DMF in immunomodulation remain unclear. Here, we found that DMF suppresses cGAS-STING activation induced by HSV-1, hering testis DNA, and mitochondrial DNA in a variety of cells. DMF significantly reduces hepatic I/R injury and inhibits cGAS-STING pathway activation in mice. The alleviating effect of DMF on hepatic I/R injury was negligible in STING-knockout mice. Mech</pubmed_abstract><journal>MedComm</journal><pagination>e70077</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11773390</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Dimethyl fumarate alleviate hepatic ischemia-reperfusion injury through suppressing cGAS-STING signaling.</pubmed_title><pmcid>PMC11773390</pmcid><pubmed_authors>Xiong Y</pubmed_authors><pubmed_authors>Qiu X</pubmed_authors><pubmed_authors>Liang W</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Qiu D</pubmed_authors><pubmed_authors>Qin Y</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Song J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Dimethyl fumarate alleviate hepatic ischemia-reperfusion injury through suppressing cGAS-STING signaling.</name><description>Hepatic ischemia-reperfusion (I/R) injury frequently occurs during the perioperative phase of liver surgery. Inappropriate activation of STING signaling can trigger excessive inflammation response to aggravate hepatic I/R injury. Dimethyl fumarate (DMF) is an FDA-approved immunomodulatory drug used to treat multiple sclerosis and psoriasis due to its notable anti-inflammation properties. However, the mechanism and targets of DMF in immunomodulation remain unclear. Here, we found that DMF suppresses cGAS-STING activation induced by HSV-1, hering testis DNA, and mitochondrial DNA in a variety of cells. DMF significantly reduces hepatic I/R injury and inhibits cGAS-STING pathway activation in mice. The alleviating effect of DMF on hepatic I/R injury was negligible in STING-knockout mice. Mech</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-04-04T20:56:44.76Z</modification><creation>2025-04-04T20:56:44.76Z</creation></dates><accession>S-EPMC11773390</accession><cross_references><pubmed>39877286</pubmed><doi>10.1002/mco2.70077</doi></cross_references></HashMap>